Clinical Site

Miami, Florida 33186

5 studies enrolling now · 20 studies all time

What they study most

Acne Inversa, Bipolar Depression, Bipolar Disorder, Manic, Blood Pressure, Diabetes Mellitus, Type 2, Diabetic Foot Ulcer, Fatty Liver, Nonalcoholic, Generalized Anxiety Disorder, Hidradenitis Suppurativa, Hypertriglyceridemia, Major Depressive Disorder, NAFLD

Studies at this site

• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis — Recruiting now
• Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis — Enrolling by invitation
• Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease — Completed
• Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania — Completed
• Study of Lumateperone in the Treatment of Patients With Bipolar Mania — Completed
• Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
• A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa — Enrolling by invitation
• An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN) — Running, not enrolling
• Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression — Completed
• Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder — Completed
• Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) — Completed
• A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects — Completed
• Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa — Completed
• Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression — Completed
• Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally — Completed
• Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease — Completed
• A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers — Status unconfirmed